Tag: AAA-SHAPE
Shape Memory Medical announces first patient treated in the AAA-SHAPE randomised...
Shape Memory Medical recently announced that the first patient has been treated in the AAA-SHAPE pivotal trial.
AAA-SHAPE (Abdominal aortic aneurysm sac healing and prevention...
Shape Memory Medical advances endovascular embolisation by completing $38 million in...
Shape Memory Medical has announced that it has completed $38 million in Series C financing, which has been led by Earlybird Venture Capital, along...
Active sac management represents “step forward” for EVAR
"Despite significant technological improvements since its inception, endovascular repair of abdominal aortic aneurysms (AAAs) is still associated with some of the same problems we...
One-year results from AAA-SHAPE trial to be presented at VEITH 2023
Shape Memory Medical, developer of custom shape memory polymers for endovascular markets, announced that one-year data from the AAA-SHAPE safety trial will be presented...
Shape Memory Medical receives US FDA IDE approval to initiate head-to-head...
Shape Memory Medical recently announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin...
Shape memory polymer: “Another step down the road” toward active aneurysm...
“There is an increasing awareness that we need to get aneurysm sacs to regress after endovascular aneurysm repair ,” Andrew Holden (Auckland, New Zealand)...
